[
    [
        {
            "time": "2021-10-29",
            "original_text": "金域医学(603882.SH)股东国创开元累计减持16万股 减持期过半 减持股份",
            "features": {
                "keywords": [
                    "金域医学",
                    "国创开元",
                    "减持",
                    "16万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学(603882.SH)股东国创开元累计减持16万股 减持期过半 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-29",
            "original_text": "金域医学：国创开元累计减持16万股股份，减持时间过半 减持股份",
            "features": {
                "keywords": [
                    "金域医学",
                    "国创开元",
                    "减持",
                    "时间过半"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "金域医学：国创开元累计减持16万股股份，减持时间过半 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-10-29",
            "original_text": "医药生物行业点评报告：《“十四五”全民医疗保障规划》发布 进一步推进医疗保障高质量发展",
            "features": {
                "keywords": [
                    "医药生物",
                    "十四五",
                    "全民医疗保障",
                    "高质量发展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业点评报告：《“十四五”全民医疗保障规划》发布 进一步推进医疗保障高质量发展",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-10-29",
            "original_text": "关注高端医疗技术国产替代加速、精选三季报有望超预期高增长个股",
            "features": {
                "keywords": [
                    "高端医疗技术",
                    "国产替代",
                    "三季报",
                    "高增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "关注高端医疗技术国产替代加速、精选三季报有望超预期高增长个股",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-10-29",
            "original_text": "广州金域医学检验集团股份有限公司 2021年第三季度报告",
            "features": {
                "keywords": [
                    "金域医学",
                    "第三季度报告",
                    "2021年"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "广州金域医学检验集团股份有限公司 2021年第三季度报告",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]